DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Compazine (Prochlorperazine Maleate) - Indications and Dosage



Prochlorperazine 25 mg suppositories are indicated in the control of severe nausea and vomiting in adults.


Adults: Dosage should be increased more gradually in debilitated or emaciated patients.
Elderly Patients: In general, dosages in the lower range are sufficient for most elderly patients. Since they appear to be more susceptible to hypotension and neuromuscular reactions, such patients should be observed closely. Dosage should be tailored to the individual, response carefully monitored and dosage adjusted accordingly. Dosage should be increased more gradually in elderly patients.
To Control Severe Nausea and Vomiting: Adjust dosage to the response of the individual. Begin with the lowest recommended dosage.
Rectal Dosage: 25 mg twice daily.


Compazine® Prochlorperazine Suppositories USP, 25mg (for adults) are easy to open, and available in boxes of 12.
12’s – NDC 66213-200-12
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Do not remove from wrapper until ready to use.

Manufactured for PBM Pharmaceuticals, Inc.
Charlottesville, VA 22902
2202921 Rev 04-13 A

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017